摘要
目的观察布地奈德混悬液治疗儿童支气管哮喘的临床疗效。方法50例支气管哮喘患儿随机分为治疗组24例和对照组26例。两组均给予常规治疗,治疗组加用布地奈德混悬液雾化吸入治疗。结果治疗1周后,治疗组在改善呼吸困难、喘息、咳嗽、减少哮鸣音、缩短住院时间以及改善肺功能PEF%、FEV1%方面与对照组比较,差异均有统计学意义(P<0.05)。治疗组不良反应少。结论布地奈德雾化吸入治疗儿童支气管哮喘急性发作疗效确切、安全,值得推广。
Objective To observe the clinical ettqcacy of budesonide suspension in children asthma.Mellaods 50 patients with bronchial asthma were randomly divided into two groups：the treatment group with 24 cases and the control group with 26 cases. The two groups were given conventional therapy, except that the treatment group was given budesonide suspension aerosol therapy. Results After lweek,eompared with the control group, the dyspnea, gasping, coughing, wheezing improved, the length of stay shortened and the lung function parameters, including PEF%, FEV1% improved in the treatment group. The differences between the two groups were statistically significant （ P 〈 0.05 ）. The adverse reaction in the treatment group was little. Conclusion In the treatment of children with acute asthma attack, budesonide aerosol therapy is of effective, safe and worth popularizing.
出处
《四川医学》
CAS
2008年第12期1654-1656,共3页
Sichuan Medical Journal
